Post-translational modifications in neurodegeneration

被引:27
作者
Didonna, Alessandro [1 ]
Benetti, Federico [2 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA
[2] ECSIN, Viale Porta Adige 45, I-45100 Rovigo, Italy
关键词
post-translational modifications; neurodegeneration; phosphorylation; acetylation; glycosylation; acylation; ubiquitination; SUMOylation; deamidation; oxidation;
D O I
10.3934/biophy.2016.1.27
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Post-translational modifications increase proteome functionality for managing all aspects of normal cell biology. They are based on the covalent attachment of functional groups, leading to phosphorylation, acetylation, glycosylation, acylation, ubiquitination, SUMOylation and oxidation of protein targets. Post-translational modifications occur at any step of protein life cycle, modulating in time and space protein folding, subcellular localization and activity. Aberrant post-translational modifications of one or more culprit proteins may lead to neurodegeneration, as shown in paradigmatic neurological disorders such as Alzheimer's, Parkinson's and prion diseases. In this review, we report the most important post-translational modifications found in neurodegenerative disorders, illustrating the pathophysiological mechanisms in which they are involved. This work highlights the lack of a global framework of post-translational modifications in terms of complexity and regulation. Therefore, in the next future many efforts are required to describe the interplay existing between post-translational modifications and their combinatorial patterns on protein targets.
引用
收藏
页码:27 / 49
页数:23
相关论文
共 169 条
[21]   The cyclooxygenases [J].
Chandrasekharan, NV ;
Simmons, DL .
GENOME BIOLOGY, 2004, 5 (09)
[22]   HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons [J].
Chen, Sigeng ;
Owens, Geoffrey C. ;
Makarenkova, Helen ;
Edelman, David B. .
PLOS ONE, 2010, 5 (05)
[23]   Anchorless prion protein results in infectious amyloid disease without clinical scrapie [J].
Chesebro, B ;
Trifilo, M ;
Race, R ;
Meade-White, K ;
Teng, C ;
LaCasse, R ;
Raymond, L ;
Favara, C ;
Baron, G ;
Priola, S ;
Caughey, B ;
Masliah, E ;
Oldstone, M .
SCIENCE, 2005, 308 (5727) :1435-1439
[24]   Signaling to chromatin through histone modifications [J].
Cheung, P ;
Allis, CD ;
Sassone-Corsi, P .
CELL, 2000, 103 (02) :263-271
[25]   Cell surface protein glycosylation in cancer [J].
Christiansen, Maja N. ;
Chik, Jenny ;
Lee, Ling ;
Anugraham, Merrina ;
Abrahams, Jodie L. ;
Packer, Nicolle H. .
PROTEOMICS, 2014, 14 (4-5) :525-546
[26]   Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease [J].
Chua, Jason P. ;
Reddy, Satya L. ;
Yu, Zhigang ;
Giorgetti, Elisa ;
Montie, Heather L. ;
Mulcherjee, Sarmistha ;
Higgins, Jake ;
McEachin, Richard C. ;
Robins, Diane M. ;
Merry, Diane E. ;
Iniguez-Lluhi, Jorge A. ;
Lieberman, Andrew P. .
JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (02) :831-845
[27]   Nitric oxide, S-nitrosylation and neurodegeneration [J].
Chung, KKK ;
Dawson, TM ;
Dawson, VL .
CELLULAR AND MOLECULAR BIOLOGY, 2005, 51 (03) :247-254
[28]   Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting [J].
Ciechanover, A .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (09) :1178-1190
[29]   The acetylation of tau inhibits its function and promotes pathological tau aggregation [J].
Cohen, Todd J. ;
Guo, Jing L. ;
Hurtado, David E. ;
Kwong, Linda K. ;
Mills, Ian P. ;
Trojanowski, John Q. ;
Lee, Virginia M. Y. .
NATURE COMMUNICATIONS, 2011, 2
[30]   Finishing the euchromatic sequence of the human genome [J].
Collins, FS ;
Lander, ES ;
Rogers, J ;
Waterston, RH .
NATURE, 2004, 431 (7011) :931-945